Monday, September 14, 2026

North Korea’s Disturbing New Strategy: Are They Waging War with Sound?

Recent reports indicate that North Korea has been conducting noise attacks toward South Korea in border areas.

Kim Jong Un Dismisses Deputy Prime Minister Yang Seung-ho: What This Means for North Korea’s Leadership Ahead of the 9th Party Congress

Kim Jong Un dismissed Deputy PM Yang Seung-ho, criticizing incompetence in leadership during a modernization ceremony at Ryongsong Complex.

North Korea’s 9th Party Congress: What Key Policies Will Be Revealed?

North Korea's 9th Party Congress emphasizes internal unity and policy proposals, while keeping discussions and outcomes largely undisclosed.

Tag: lung cancer

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

TXN10128: Breakthrough Oral ENPP1 Inhibitor Shows 44.4% Tumor Reduction in EGFR Mutation Lung Cancer

TXINNO Bioscience's new drug trial shows tumor reduction in 4 out of 9 patients with EGFR-mutated lung cancer who failed prior treatments.

Top 5 Promising Lung Cancer Treatments Revealed at WCLC 2026: What You Need to Know

The world's largest conference on lung cancer will be held in Seoul after 19 years, showcasing clinical results from local pharmaceutical firms.

8,000 Lung Cancer Experts to Gather in Seoul for International Conference After 19 Years

About 8,000 lung cancer experts will gather in Seoul for WCLC 2026, marking the city's first hosting of the international conference in 19 years.

Pharos iBio and Kolon Pharmaceutical Expand Joint Development of Lung Cancer Drug

Pharos iBio and Kolon Pharmaceutical are stepping up development of PHI-701, a next-generation EGFR inhibitor targeting patients who have developed resistance to existing targeted lung cancer treatments.

GIST Maps Out the Cascade of Cellular Interactions During Early Stages of Lung Cancer

South Korean researchers unveil how mutated cells create a cancer-friendly environment in early lung cancer, paving the way for early interventions.

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

Is Your Cough a Warning Sign? Understanding Small Cell Lung Cancer and Its Treatment Advances

Lung cancer often shows no clear symptoms early on, making late detection common despite persistent cough or phlegm.

NCCN Endorses Leclaza and Rybrevant Combo as Top Lung Cancer Treatment: What You Need to Know

NCCN guidelines now classify Leclaza + Rybrevant as a preferred first-line treatment for lung cancer, enhancing patient access and management.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Cigarettes vs. DNA: Study Shows Smoking Is the Real Cancer Trigger

A study shows that smoking for over 20 years increases small-cell lung cancer risk by 54 times, highlighting smoking's dangers.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

New South Korean Tech Detects Lung Cancer Early with Only 5 Drops of Blood

A South Korean team developed a blood test for early lung cancer detection, achieving 100% accuracy in identifying key mutations.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.